317 related articles for article (PubMed ID: 6124265)
21. A review of the haemodynamic effects of labetalol in man.
Cohn JN; Mehta J; Francis GS
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):19S-26S. PubMed ID: 7093099
[TBL] [Abstract][Full Text] [Related]
22. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
23. Raynaud's phenomenon caused by beta-receptor blocking drugs. Improvement after treatment with a combined alpha- and beta-blocker.
Eliasson K; Danielson M; Hylander B; Lindblad LE
Acta Med Scand; 1984; 215(4):333-9. PubMed ID: 6145298
[TBL] [Abstract][Full Text] [Related]
24. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
Hansson L; Hänel B
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):763-4. PubMed ID: 10952
[TBL] [Abstract][Full Text] [Related]
25. Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population.
Xie RH; Guo Y; Krewski D; Mattison D; Nerenberg K; Walker MC; Wen SW
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):281-5. PubMed ID: 24139131
[TBL] [Abstract][Full Text] [Related]
26. "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
McAreavey D; Ramsey LE; Latham L; McLaren AD; Lorimer AR; Reid JL; Robertson JI; Robertson MP; Weir RJ
Br Med J (Clin Res Ed); 1984 Jan; 288(6411):106-11. PubMed ID: 6419809
[TBL] [Abstract][Full Text] [Related]
27. Antihypertensive drugs: clinical pharmacology and therapeutic use.
Wollam GL; Gifford RW; Tarazi RC
Drugs; 1977 Dec; 14(6):420-60. PubMed ID: 23284
[No Abstract] [Full Text] [Related]
28. Pharmacologic and physiologic considerations of adrenoceptor blockade.
Frohlich ED; Dunn FG; Messerli FH
Am J Med; 1983 Oct; 75(4A):9-14. PubMed ID: 6139019
[TBL] [Abstract][Full Text] [Related]
29. Labetalol in resistant hypertension.
Hedstrand H
Acta Med Scand Suppl; 1982; 665():125-8. PubMed ID: 6961758
[TBL] [Abstract][Full Text] [Related]
30. Use of labetalol in moderate to severe hypertension.
Macdonald I; Hua AS; Thomas GW; Woo KT; Whitworth JA; Kincaid-Smith P
Med J Aust; 1980 Apr; 1(7):325-7. PubMed ID: 7393061
[TBL] [Abstract][Full Text] [Related]
31. Haemodynamic effects of long-term oral labetalol.
Edwards RC; Raftery EB
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
[TBL] [Abstract][Full Text] [Related]
32. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
[No Abstract] [Full Text] [Related]
33. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
[TBL] [Abstract][Full Text] [Related]
34. Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
Barnett AJ; Kalowski S; Guest C
Med J Aust; 1978 Jan; 1(2):105-9. PubMed ID: 349319
[TBL] [Abstract][Full Text] [Related]
35. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
Koch G
J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S30-41. PubMed ID: 6169958
[TBL] [Abstract][Full Text] [Related]
36. Review of long-term treatment with labetalol.
Waal-Manning HJ; Simpson FO
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):65S-73S. PubMed ID: 6980012
[TBL] [Abstract][Full Text] [Related]
37. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
38. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
Koch G
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
[TBL] [Abstract][Full Text] [Related]
39. Labetalol: an alpha- and beta-blocker.
Conner CS
Drug Intell Clin Pharm; 1983; 17(7-8):543-4. PubMed ID: 6135593
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent.
Hansson L; Hänel B
Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):195-8. PubMed ID: 12115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
